All trials
NCT04430517EARLY PHASE1ACTIVE NOT RECRUITINGAPOE4-explicit

Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

Eligibility check — Phoenix members

Phoenix members see for THIS trial:

  • APOE genotype match
  • Cognitive status fits inclusion
  • Specific exclusions flagged
  • Distance to nearest site
Check my eligibility — become a member
Sites
1 location
Start
2022-03-02

Interventions tested

  • DRUGNicotinamide riboside
View full record on ClinicalTrials.gov

We use cookies to enhance your experience.